Publication
Potential leveraged buyout of dermapharm holding se: company overview
| Summary: | The following paper focuses on the development of an investment thesis and a respective value creation strategy for the potential leveraged buyout of Dermapharm Holding SE, a German developer, producer, and distributor of niche prescription and over-the-counter pharmaceuticals. It evaluates the historic financials, the business model with a focus on what differentiates the company from the competition and an analysis on the growth and profitability mix and operational performance. |
|---|---|
| Main Authors: | Kempf, Maximilian Josef Wolfgang |
| Subject: | Private equity challenge Corporate finance Private equity Capital structure Leveraged buyout Field lab Company overview Dermapharm se holding Specialty pharmaceuticals & generics |
| Year: | 2022 |
| Country: | Portugal |
| Document type: | master thesis |
| Access type: | embargoed access |
| Associated institution: | Universidade Nova de Lisboa |
| Language: | English |
| Origin: | Repositório Institucional da UNL |
| Summary: | The following paper focuses on the development of an investment thesis and a respective value creation strategy for the potential leveraged buyout of Dermapharm Holding SE, a German developer, producer, and distributor of niche prescription and over-the-counter pharmaceuticals. It evaluates the historic financials, the business model with a focus on what differentiates the company from the competition and an analysis on the growth and profitability mix and operational performance. |
|---|